Sartorius Stedim Biotech S.A. (EPA:DIM)
France · Delayed Price · Currency is EUR 211.80
-3.20 (-1.49%)
Oct 19, 2026, 5:35 PM CET
Sartorius Stedim Biotech Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Sartorius Stedim Biotech stock has a consensus rating of "Buy" and an average price target of €237.29. The average 1-year stock price forecast is 12.03% higher than the current stock price, while the lowest is €210.00 (-0.85%) and the highest is €262.00 (+23.70%).
Price Target: €237.29 (+12.03%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sartorius Stedim Biotech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 8 | 8 | 8 |
| Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Hold | 1 | 1 | 1 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains €260.00 | Buy | Maintains | €260.00 | +22.76% | Oct 15, 2026 |
| RBC Capital | RBC Capital | Buy Maintains €210.00 | Buy | Maintains | €210.00 | -0.85% | Oct 6, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains €208.00 → €223.00 | Buy | Maintains | €208.00 → €223.00 | +5.29% | Oct 1, 2026 |
| Barclays | Barclays | Buy Maintains €240.00 → €250.00 | Buy | Maintains | €240.00 → €250.00 | +18.04% | Sep 30, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains €260.00 | Buy | Maintains | €260.00 | +22.76% | Sep 28, 2026 |
Financial Forecast
Revenue This Year
3.13B
from 2.97B
Increased by 5.57%
Revenue Next Year
3.48B
from 3.13B
Increased by 11.04%
EPS This Year
4.99
from 4.40
Increased by 13.48%
EPS Next Year
6.02
from 4.99
Increased by 20.50%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.